Lathuiliere, AurelienMach, NicolasSchneider, Bernard L.2015-09-282015-09-282015-09-28201510.3390/ijms160510578https://infoscience.epfl.ch/handle/20.500.14299/119418WOS:000356241400087Ex vivo gene therapy using retrievable encapsulated cellular implants is an effective strategy for the local and/or chronic delivery of therapeutic proteins. In particular, it is considered an innovative approach to modulate the activity of the immune system. Two recently proposed therapeutic schemes using genetically engineered encapsulated cells are discussed here: the chronic administration of monoclonal antibodies for passive immunization against neurodegenerative diseases and the local delivery of a cytokine as an adjuvant for anti-cancer vaccines.cellular implantsgenetic engineeringencapsulationpassive immunizationrecombinant antibodiesAlzheimer's diseasecytokineadjuvantcancer vaccinetext::journal::journal article::review article